Evidence based management of hypertension: What are the elements of good treatment for hypertension?

British Medical Journal

Volumn 322, Issue 7294, 2001, Pages 1107-1109

  Mulrow, C D ^a   Pignone, M ^b  

^a UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; AMILORIDE; AMLODIPINE; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CHLORTALIDONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXAZOSIN; ENALAPRIL; FELODIPINE; FOSINOPRIL; HYDROCHLOROTHIAZIDE; ISRADIPINE; LISINOPRIL; NIFEDIPINE; NISOLDIPINE; PLACEBO; POTASSIUM SPARING DIURETIC AGENT; RAMIPRIL; THIAZIDE DIURETIC AGENT; TRIAMTERENE; ANTIHYPERTENSIVE AGENT;

ANKLE EDEMA; CANCER RISK; CARDIOVASCULAR RISK; CLINICAL TRIAL; COUGHING; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG EFFECT; DRUG SAFETY; DRUG TOLERABILITY; EVIDENCE BASED MEDICINE; HUMAN; HYPERTENSION; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRACTICE GUIDELINE; PRIMARY HEALTH CARE; PRIORITY JOURNAL; REVIEW; SEXUAL DYSFUNCTION; TREATMENT INDICATION; CEREBROVASCULAR ACCIDENT; RISK ASSESSMENT;

ANTIHYPERTENSIVE AGENTS; CEREBROVASCULAR ACCIDENT; HUMANS; HYPERTENSION; RISK ASSESSMENT;

EID: 0035810566     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.322.7294.1107     Document Type: Review

References (26)

1. What are the elements of good treatment for hypertension?
2. New meta-analysis of treatment trials of hypertension: Improving the estimate of therapeutic benefit
3. Efficacy of treating hypertension in women
4. Quality of life in treatment of hypertension. A metaanalysis of clinical trials
5. The effects of antihypertensive therapy on the quality of life
6. Choosing a first-line drug in the management of elevated blood pressure: What is the evidence? 1. Thiazide diuretics
7. Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis
8. Systematic review of antihypertensive therapies: Does the evidence assist in choosing a first-line drug?
9. Are beta-blockers efficacious as first-line therapy for hypertension in the elderly? A systematic review
10. Choosing a first-line drug in the management of elevated blood pressure: What is the evidence? 2. Beta-blockers
11. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patient
12. Effects of ACE inhibitors, calcium antagonists, and other blood pressure-lowering drugs on mortality and major cardiovascular morbidity
13. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
14. Randomised trial of old and new antihypertensive drugs in elderly patients: Cardiovascular mortality and morbidity the Swedish Trial in old Patients with Hypertension-2 study
15. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: The Captopril Prevention Project (CAPPP) randomised trial
16. Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events. Randomized Trial (FACET) in patients with hypertension and NIDDM
17. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension
18. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39
19. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
20. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a goal in hypertension treatment (INSIGHT)
21. Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: The Nordic Diltiazem (NORDIL) study
22. Treatment of mild hypertension study. Final results
23. Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo
24. Randomised, double blind, multicentre comparison of hydrochlorothiazide, atenolol, nitrendipine, and enalapril in antihypertensive treatment: Results of the HANE study
25. Calcium-channel blockers for hypertension - Uncertainty continues
26. Does diuretic therapy increase the risk of renal cell carcinoma?